"Ciprofloxacin Lactate and Sodium Chloride Injection"has passed the evaluation of generic drug quality and efficacy consistency

   Congratulations to Shijiazhuang No.4 Pharmaceutical for its "Ciprofloxacin Lactate and Sodium Chloride Injection", which has been reviewed by relevant authorities and has passed the evaluation of generic drug quality and efficacy consistency.

  The ‘Approval Notice of Supplementary Drug Application ‘has been issued to our company after being approved by the State Drug Administration on January 05, 2021.

  This news makes concentric anti-epidemic, has not interrupted the research and development work of Shijiazhuang No.4 Pharmaceutical science and technology personnel greatly encouraged.

  In the past two years, Shijiazhuang No.4 Pharmaceutical has made concerted efforts in the development of innovative drugs, generic drugs and API drugs as well as the research on consistency evaluation. The innovative achievements have accumulated steadily.   

   At the beginning of the New Year, three specifications of ambroxol hydrochloride injection produced by Shijiazhuang No.4 Pharmaceutical also passed the generic drug quality and efficacy consistency evaluation among national pharmaceutical enterprises earlier.

  Up to now, Shijiazhuang No.4 Pharmaceutical has 9 varieties and a total of 13 product regulation products through the national generic drug quality and efficacy consistency evaluation or regarded as passed the consistency evaluation, the number and progress of the evaluation is in the leading level in the industry.